Skip to main content


Company Information

Company Profile

Cidara is developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California.

IR Contacts

Cidara Contact
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
(858) 752-6170

Investor Contact
Brian Ritchie
LifeSci Advisors
(212) 915-2578

Media Contact
Veronica Eames
LifeSci Communications

Transfer Agent
American Stock Transfer & Trust Company
(800) 937-5449

Whistleblower Hotline
Leave a Confidential Message
(866) 760-2381

Frequently Asked Questions

When was Cidara founded?

Cidara was founded in 2012.

Where is Cidara incorporated?

Cidara was incorporated in Delaware in December 2012 as K2 Therapeutics, Inc. and its name was changed to Cidara Therapeutics, Inc. in July 2014.

Where is Cidara's corporate headquarters?

6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
(858) 752-6170

Who are the members of Cidara's Board of Directors?

You can view our Board of Directors by visiting the “Board of Directors” section of our website.

Who are the members of Cidara's management team?

You can view our management team by visiting the “Management Team” section of our website.

On which exchange is Cidara listed and what is the ticker symbol?

Cidara is traded on The NASDAQ Global Market under the symbol “CDTX.”

When did Cidara go public?

Cidara went public on April 15, 2015.

How can I purchase shares?

Shares can be purchased through a stockbroker of your choice.

Does Cidara have a direct stock purchase plan?

Cidara does not currently offer a direct stock purchase plan.

Does Cidara pay dividends and have a dividend reinvestment program?

Currently, Cidara does not offer a dividend or a dividend reinvestment program

Who is Cidara's transfer agent and how do I contact them?

Cidara’s transfer agent is America Stock Transfer & Trust Company, LLC. You can find more information about how to contact America Stock Transfer & Trust Company at:

American Stock Transfer & Trust Company, LLC.
6201 15th Avenue
Brooklyn, New York 11219
(800) 937-5449

How can I replace my lost stock certificates?

Please contact our transfer agent American Stock Transfer & Trust Company, LLC. (AST) at or 800-937-5449. Our Transfer Agent can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.

How do I report a change of mailing address?

You must send both your old and new addresses to our transfer agent, 800-937-5449,, by U.S. mail. Each stockholder in question must sign the request for an address change.

How can I get a copy of your Annual Report or any other investor materials such as an Investor Relations kit or 10-K?

Quarterly & Annual Reports and other investor materials, when available, can be found in the “SEC Filings” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at

Where can I find recent Cidara press releases?

You can view our recent press releases by visiting the “Press Releases” section of our website.

Where can I find more information on Cidara's R&D programs?

You can view information on our development programs by visiting the “Pipeline” section of our website.

How do I contact Investor Relations with a question or request?

For investor related media inquiries, please send an email to For all other media related inquiries, please send an email to